↓ Skip to main content

Dove Medical Press

Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
39 Mendeley
Title
Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential
Published in
Therapeutics and Clinical Risk Management, October 2020
DOI 10.2147/tcrm.s230592
Pubmed ID
Authors

Constantine E Kosmas, Alba Muñoz Estrella, Andreas Skavdis, Edilberto Peña Genao, Ian Martinez, Eliscer Guzman

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 15%
Student > Master 4 10%
Professor > Associate Professor 3 8%
Student > Ph. D. Student 3 8%
Other 2 5%
Other 6 15%
Unknown 15 38%
Readers by discipline Count As %
Medicine and Dentistry 9 23%
Pharmacology, Toxicology and Pharmaceutical Science 5 13%
Biochemistry, Genetics and Molecular Biology 3 8%
Nursing and Health Professions 2 5%
Agricultural and Biological Sciences 1 3%
Other 3 8%
Unknown 16 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2022.
All research outputs
#3,624,585
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#177
of 1,323 outputs
Outputs of similar age
#90,383
of 432,292 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 13 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,292 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.